Canada · Delayed Price · Currency is CAD Rapid Dose Therapeutics Statistics
Total Valuation
CSE:DOSE has a market cap or net worth of CAD 14.33 million. The enterprise value is 19.64 million.
| Market Cap | 14.33M |
| Enterprise Value | 19.64M |
Important Dates
The next estimated earnings date is Friday, July 24, 2026.
| Earnings Date | Jul 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:DOSE has 136.44 million shares outstanding. The number of shares has increased by 6.73% in one year.
| Current Share Class | 136.44M |
| Shares Outstanding | 136.44M |
| Shares Change (YoY) | +6.73% |
| Shares Change (QoQ) | +3.88% |
| Owned by Insiders (%) | 15.14% |
| Owned by Institutions (%) | n/a |
| Float | 115.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.17 |
| PB Ratio | -2.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -19.61 |
| Interest Coverage | -1.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -55.19% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 42.06% |
| Weighted Average Cost of Capital (WACC) | 5.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.13 |
| Inventory Turnover | 6.78 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is -0.65, so CSE:DOSE's price volatility has been lower than the market average.
| Beta (5Y) | -0.65 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 54.48 |
| Average Volume (20 Days) | 38,591 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:DOSE had revenue of CAD 2.77 million and -3.39 million in losses. Loss per share was -0.03.
| Revenue | 2.77M |
| Gross Profit | 1.36M |
| Operating Income | -2.17M |
| Pretax Income | -3.39M |
| Net Income | -3.39M |
| EBITDA | -1.66M |
| EBIT | -2.17M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 11,554 in cash and 5.32 million in debt, with a net cash position of -5.31 million or -0.04 per share.
| Cash & Cash Equivalents | 11,554 |
| Total Debt | 5.32M |
| Net Cash | -5.31M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -7.18M |
| Book Value Per Share | -0.05 |
| Working Capital | -8.08M |
Cash Flow
In the last 12 months, operating cash flow was -270,394 and capital expenditures -899, giving a free cash flow of -271,293.
| Operating Cash Flow | -270,394 |
| Capital Expenditures | -899 |
| Depreciation & Amortization | 513,442 |
| Net Borrowing | 262,130 |
| Free Cash Flow | -271,293 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 49.15%, with operating and profit margins of -78.29% and -122.22%.
| Gross Margin | 49.15% |
| Operating Margin | -78.29% |
| Pretax Margin | -122.22% |
| Profit Margin | -122.22% |
| EBITDA Margin | -59.78% |
| EBIT Margin | -78.29% |
| FCF Margin | n/a |
Dividends & Yields
CSE:DOSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.73% |
| Shareholder Yield | -6.73% |
| Earnings Yield | -23.66% |
| FCF Yield | -1.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |